Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Curated Information Page > Cst Curation Set #705
Moritz A (2005) CST Curation Set: 705; Year: 2005; Biosample/Treatment: cell line, K562/-; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (K/R)XX[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Ser/Thr) Akt Substrate Antibody Cat#: 9611
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S50-p - Abl (human)
Modsite: sEAARWNsKENLLAG SwissProt Entrez-Gene
Orthologous residues
Abl (human): S50‑p, Abl iso2 (human): S69‑p, Abl (mouse): S50‑p, Abl iso4 (mouse): S69‑p, Abl (rat): S50‑p, Abl iso2 (rat): S69‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T1023-p - ANKRD27 (human)
Modsite: RRMLRRHtVEDAVVs SwissProt Entrez-Gene
Orthologous residues
ANKRD27 (human): T1023‑p, ANKRD27 (mouse): T1022‑p, ANKRD27 (rat): T1028‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T531-p - ARHGEF10L (human)
Modsite: SsLNKLLtsGQRQLL SwissProt Entrez-Gene
Orthologous residues
ARHGEF10L (human): T531‑p, ARHGEF10L (mouse): T529‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S532-p - ARHGEF10L (human)
Modsite: sLNKLLtsGQRQLLL SwissProt Entrez-Gene
Orthologous residues
ARHGEF10L (human): S532‑p, ARHGEF10L (mouse): S530‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S1019-p - CEP170 (human)
Modsite: sGRIRQPsVDLtDDD SwissProt Entrez-Gene
Orthologous residues
CEP170 (human): S1019‑p, CEP170 iso2 (human): S921‑p, CEP170 iso3 (human): S921‑p, CEP170 (mouse): S1008‑p, CEP170 (rat): S968‑p, CEP170 (cow): S1020‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T1023-p - CEP170 (human)
Modsite: RQPsVDLtDDDQtsS SwissProt Entrez-Gene
Orthologous residues
CEP170 (human): T1023‑p, CEP170 iso2 (human): T925‑p, CEP170 iso3 (human): T925‑p, CEP170 (mouse): T1012‑p, CEP170 (rat): T972‑p, CEP170 (cow): T1024‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T1028-p - CEP170 (human)
Modsite: DLtDDDQtsSVPHsA SwissProt Entrez-Gene
Orthologous residues
CEP170 (human): T1028‑p, CEP170 iso2 (human): T930‑p, CEP170 iso3 (human): T930‑p, CEP170 (mouse): T1017‑p, CEP170 (rat): T977‑p, CEP170 (cow): T1029‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S21-p - EEF1A1 (human)
Modsite: GHVDSGkstttGHLI SwissProt Entrez-Gene
Orthologous residues
EEF1A1 (human): S21‑p, EEF1A1 (mouse): S21‑p, EEF1A1 (rat): S21‑p, EEF1A1 (rabbit): S21‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S21-p - EEF1A2 (human)
Modsite: GHVDSGkstttGHLI SwissProt Entrez-Gene
Orthologous residues
EEF1A2 (human): S21‑p, EEF1A2 (mouse): S21‑p, EEF1A2 (rat): S21‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S584-p - eIF3-theta (human)
Modsite: ERKERLEsLNIQREk SwissProt Entrez-Gene
Orthologous residues
eIF3‑theta (human): S584‑p, eIF3‑theta (mouse): S584‑p, eIF3‑theta (rat): S584‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S1220-p - FAM208B (human)
Modsite: tTLGRQCsLNCISSG SwissProt Entrez-Gene
Orthologous residues
FAM208B (human): S1220‑p, FAM208B (mouse): S1213‑p, FAM208B (rat): S1217‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S151-p - FAM82A2 (human)
Modsite: FVRERsDstGsssVY SwissProt Entrez-Gene
Orthologous residues
FAM82A2 (human): S151‑p, FAM82A2 (mouse): S151‑p, FAM82A2 (rat): S151‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T152-p - FAM82A2 (human)
Modsite: VRERsDstGsssVYF SwissProt Entrez-Gene
Orthologous residues
FAM82A2 (human): T152‑p, FAM82A2 (mouse): T152‑p, FAM82A2 (rat): T152‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T1270-p - FRMPD2 (human)
Modsite: HQERDEStLATSLEK SwissProt Entrez-Gene
Orthologous residues
FRMPD2 (human): T1270‑p, FRMPD2 (mouse): A1255‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T262-p - GFAT (human)
Modsite: NLsRVDsttCLFPVE SwissProt Entrez-Gene
Orthologous residues
GFAT (human): T262‑p, GFAT iso2 (human): T244‑p, GFAT (mouse): T260‑p, GFAT iso2 (mouse): T244‑p, GFAT (rat): T244‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S4623-p - GPR98 (human)
Modsite: KGEAKLDsRAKDVTL SwissProt Entrez-Gene
Orthologous residues
GPR98 (human): S4623‑p, GPR98 (mouse): P4617‑p, GPR98 iso2 (mouse): , GPR98 (rat): P1959‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T1472-p - HERC2 (human)
Modsite: IEQVkHRtLPKSVVD SwissProt Entrez-Gene
Orthologous residues
HERC2 (human): T1472‑p, HERC2 (mouse): T1473‑p, HERC2 iso2 (mouse): T1473‑p, HERC2 (rat): A1416‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T295-p - IFNGR1 (human)
Modsite: IsVVRsAtLEtkPEs SwissProt Entrez-Gene
Orthologous residues
IFNGR1 (human): T295‑p, IFNGR1 (mouse): T302‑p, IFNGR1 (rat): T289‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S43-p - K8 (human)
Modsite: ssFsrVGssNFrGGL SwissProt Entrez-Gene
Orthologous residues
K8 (human): S43‑p, K8 iso2 (human): S71‑p, K8 (mouse): S43‑p, K8 (rat): S43‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S44-p - K8 (human)
Modsite: sFsrVGssNFrGGLG SwissProt Entrez-Gene
Orthologous residues
K8 (human): S44‑p, K8 iso2 (human): S72‑p, K8 (mouse): S44‑p, K8 (rat): S44‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S1681-p - KIDINS220 (human)
Modsite: yNLNRtPstVtLNNN SwissProt Entrez-Gene
Orthologous residues
KIDINS220 (human): S1681‑p, KIDINS220 iso2 (human): S1582‑p, KIDINS220 iso4 (human): S1662‑p, KIDINS220 (mouse): S1704‑p, KIDINS220 (rat): S1673‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T1682-p - KIDINS220 (human)
Modsite: NLNRtPstVtLNNNs SwissProt Entrez-Gene
Orthologous residues
KIDINS220 (human): T1682‑p, KIDINS220 iso2 (human): T1583‑p, KIDINS220 iso4 (human): T1663‑p, KIDINS220 (mouse): T1705‑p, KIDINS220 (rat): T1674‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S458-p - lamin A/C (human)
Modsite: FVRLRNksNEDQsMG SwissProt Entrez-Gene
Orthologous residues
lamin A/C (human): S458‑p, lamin A/C iso2 (human): S458‑p, lamin A/C iso3 (human): S458‑p, lamin A/C (mouse): S458‑p, lamin A/C iso3 (mouse): S346‑p, lamin A/C (rat): S458‑p, lamin A/C (cow): S458‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S1651-p - MRCKA (human)
Modsite: sALKREFsGGsYsAK SwissProt Entrez-Gene
Orthologous residues
MRCKA (human): S1651‑p, MRCKA iso2 (human): S1673‑p, MRCKA iso3 (human): S1557‑p, MRCKA iso6 (human): S1700‑p, MRCKA (mouse): S1638‑p, MRCKA (rat): S1651‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T700-p - NASP (human)
Modsite: MIAsRkPtDGAsssN SwissProt Entrez-Gene
Orthologous residues
NASP (human): T700‑p, NASP iso2 (human): T361‑p, NASP iso3 (human): T702‑p, NASP iso4 (human): T636‑p, NASP (mouse): T686‑p, NASP iso2 (mouse): T334‑p, NASP (rat): T688‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S324-p - OSBPL9 (human)
Modsite: SASVLtHsssGNsLK SwissProt Entrez-Gene
Orthologous residues
OSBPL9 (human): S324‑p, OSBPL9 (mouse): S324‑p, OSBPL9 (rat): S311‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S325-p - OSBPL9 (human)
Modsite: ASVLtHsssGNsLKR SwissProt Entrez-Gene
Orthologous residues
OSBPL9 (human): S325‑p, OSBPL9 (mouse): S325‑p, OSBPL9 (rat): S312‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S326-p - OSBPL9 (human)
Modsite: SVLtHsssGNsLKRP SwissProt Entrez-Gene
Orthologous residues
OSBPL9 (human): S326‑p, OSBPL9 (mouse): S326‑p, OSBPL9 (rat): S313‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S329-p - OSBPL9 (human)
Modsite: tHsssGNsLKRPDtT SwissProt Entrez-Gene
Orthologous residues
OSBPL9 (human): S329‑p, OSBPL9 (mouse): S329‑p, OSBPL9 (rat): S316‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T335-p - OSBPL9 (human)
Modsite: NsLKRPDtTEsLNSS SwissProt Entrez-Gene
Orthologous residues
OSBPL9 (human): T335‑p, OSBPL9 (mouse): T335‑p, OSBPL9 (rat): T322‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S506-p - PKCD (human)
Modsite: IFGEsRAstFCGtPD SwissProt Entrez-Gene
Orthologous residues
PKCD (human): S506‑p, PKCD iso2 (human): S537‑p, PKCD (mouse): S504‑p, PKCD iso2 (mouse): S530‑p, PKCD (rat): S504‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T183-p - PKCH (human)
Modsite: ATYLRQPtYCSHCRE SwissProt Entrez-Gene
Orthologous residues
PKCH (human): T183‑p, PKCH (mouse): T183‑p, PKCH (rat): T183‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T112-p - Pumilio-1 (human)
Modsite: NskHRWPtGDNIHAE SwissProt Entrez-Gene
Orthologous residues
Pumilio‑1 (human): T112‑p, Pumilio‑1 iso2 (human): T112‑p, Pumilio‑1 iso3 (human): T112‑p, Pumilio‑1 iso4 (human): T148‑p, Pumilio‑1 (mouse): T112‑p, Pumilio‑1 (rat): T112‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T396-p - Pumilio-2 (human)
Modsite: GAGQRPLtPNQGQQG SwissProt Entrez-Gene
Orthologous residues
Pumilio‑2 (human): T396‑p, Pumilio‑2 iso2 (human): T396‑p, Pumilio‑2 iso3 (human): T396‑p, Pumilio‑2 iso4 (human): T340‑p, Pumilio‑2 (mouse): T395‑p, Pumilio‑2 iso2 (mouse): T395‑p, Pumilio‑2 (rat): T395‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S1219-p - RICTOR (human)
Modsite: HMKIRsQsFNtDttt SwissProt Entrez-Gene
Orthologous residues
RICTOR (human): S1219‑p, RICTOR iso3 (human): S1219‑p, RICTOR iso4 (human): , RICTOR (mouse): S1218‑p, RICTOR (rat): S1204‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T1222-p - RICTOR (human)
Modsite: IRsQsFNtDtttsGI SwissProt Entrez-Gene
Orthologous residues
RICTOR (human): T1222‑p, RICTOR iso3 (human): T1222‑p, RICTOR iso4 (human): , RICTOR (mouse): T1221‑p, RICTOR (rat): T1207‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S319-p - SCAMP2 (human)
Modsite: RTFHRAAssAAQGAF SwissProt Entrez-Gene
Orthologous residues
SCAMP2 (human): S319‑p, SCAMP2 (mouse): S319‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T82-p - SRP9 (human)
Modsite: AkEARNVtMEtE___ SwissProt Entrez-Gene
Orthologous residues
SRP9 (human): T82‑p, SRP9 iso2 (human): , SRP9 (mouse): T82‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S58-p - TPI1 (human)
Modsite: kMNGRkQsLGELIGt SwissProt Entrez-Gene
Orthologous residues
TPI1 (human): S58‑p, TPI1 iso1 (human): S21‑p, TPI1 (mouse): C71‑p, TPI1 (rat): C21‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

S555-p - UBR4 (human)
Modsite: LQRQRKGsMsSDASA SwissProt Entrez-Gene
Orthologous residues
UBR4 (human): S555‑p, UBR4 iso2 (human): S555‑p, UBR4 iso3 (human): S555‑p, UBR4 (mouse): S555‑p, UBR4 iso5 (mouse): S555‑p, UBR4 (rat): S555‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human

T149-p - USP25 (human)
Modsite: ACLKRtPtEVWRDSR SwissProt Entrez-Gene
Orthologous residues
USP25 (human): T149‑p, USP25 iso1 (human): T149‑p, USP25 iso3 (human): T149‑p, USP25 (mouse): I149‑p, USP25 (rat): I150‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  leukemia, chronic myelogenous leukemia
Relevant cell lines - cell types - tissues:  K562 (erythroid)
Cellular systems studied:  cell lines
Species studied:  human